What is Alevian duo by Novartis?

Alevian Duo is a novel treatment developed by Novartis designed to address certain autoimmune and inflammatory conditions. It combines two active ingredients to enhance therapeutic efficacy and improve patient outcomes. The treatment aims to provide a dual mechanism of action, potentially offering benefits over traditional therapies. As of my last knowledge update in October 2023, specific details about its approval status and clinical applications may vary, so it's advisable to consult recent sources for the latest information.